Patient Guide: A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 18 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05661955
Status: ACTIVE_NOT_RECRUITING
Condition: Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma, Non-mucosal Melanoma
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 18 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing, Beijing Municipality
  • Fuzhou, Fujian
  • Lanzhou, Gansu
  • • And 15 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily